Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DarioHealthDRIO -0.42%59 1-Year Share Buyback Ratio is -222.90 as of Jun. 2026. GuruFocus rates DRIO with a GF Score™ of 59/100 and a GF Value™ of $4.22 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 389 Healthcare Providers & Services companies, DarioHealth ranks worse than 96.66% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. DarioHealth's current 1-Year Share Buyback Ratio was -222.90%.
DRIO's 1-Year Share Buyback Ratio is ranked worse than 96.66% of 389
companies
in the Healthcare Providers & Services industry
Industry Median: -1.3
vs DRIO: -222.90
DarioHealth (NAS:DRIO) 1-Year Share Buyback Ratio Explanation
A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
DarioHealth 1-Year Share Buyback Ratio Related Terms
DRIO vs VASO, ONMD, CCLD: 1-Year Share Buyback Ratio Comparison
For the Health Information Services subindustry, DarioHealth's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DarioHealth 1-Year Share Buyback Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DarioHealth's 1-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where DarioHealth's 1-Year Share Buyback Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 1-Year Share Buyback Ratio of -222.90 mean?
DarioHealth (DRIO) has a 1-Year Share Buyback Ratio of -222.90 as of Jun. 2026. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for DarioHealth and its competitors. According to the industry distribution chart, DarioHealth ranks #376 out of 389 companies in the Healthcare Providers & Services industry, placing it in the top 96.7%.
Is DarioHealth's 1-Year Share Buyback Ratio too high?
DarioHealth's current 1-Year Share Buyback Ratio is -222.90. Based on the distribution chart, DarioHealth ranks #376 out of 389 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, DarioHealth has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DarioHealth's 1-Year Share Buyback Ratio compare to VASO and ONMD?
According to the Healthcare Providers & Services industry distribution chart, DarioHealth ranks #376 out of 389 companies for 1-Year Share Buyback Ratio. This places DarioHealth in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Share Buyback Ratio for a Healthcare Providers & Services company?
A good 1-Year Share Buyback Ratio depends on the Healthcare Providers & Services industry context. However, 1-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Share Buyback Ratio mean?
A high 1-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for DarioHealth and its competitors. DarioHealth's current 1-Year Share Buyback Ratio is -222.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DarioHealth stock overvalued right now?
Based on GuruFocus' analysis, DarioHealth (DRIO) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.22, compared to a current price of $7.04 — trading 66.8% above its estimated fair value. The current 1-Year Share Buyback Ratio is -222.90. DarioHealth's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Share Buyback Ratio calculated?
1-Year Share Buyback Ratio is calculated from a company's financial statements. For DarioHealth (DRIO), the current 1-Year Share Buyback Ratio is -222.90 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DarioHealth (DRIO) Overvalued in 2026?
Based on GuruFocus' analysis, DarioHealth stock appears to be overvalued.
The current stock price of $7.04 is trading 66.8% above its estimated GF Value™ of $4.22.
GuruFocus considers DarioHealth to be Significantly Overvalued.
Key valuation signals for DRIO:
1-Year Share Buyback Ratio: -222.90
GF Value™: $4.22 vs. price of $7.04 (66.8% above fair value)
No single metric tells the full story. See the DRIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DarioHealth Corp is a digital health company that provides chronic condition management programs to employers, health plans, and other payers in the United States and internationally. Its platform combines connected monitoring devices, such as blood glucose meters and blood pressure cuffs, with mobile software, data analytics, and coaching to support members managing diabetes, hypertension, weight, musculoskeletal conditions, and behavioral health. DarioHealth generates revenue primarily through business-to-business contracts with payers and employers, charging per-member or per-participant fees for access to its programs, rather than selling directly to consumers. The company has expanded its offering through acquisitions, adding musculoskeletal and behavioral health capabilities to its chronic care portfolio. Its solutions are designed to drive engagement and clinical outcomes while reducing downstream healthcare costs for its payer and employer clients.
59GF Score
Get the complete analysis for DRIO
1-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DRIO has been successfully added to your 
